Table 1. Enriched pathways in T2D interactome.

Term	Corrected p value*
Pathways in cancer	4.52E-27
Prostate cancer	2.02E-17
Chronic myeloid leukemia	4.90E-17
B cell receptor signaling pathway	3.44E-15
Pancreatic cancer	1.38E-13
Glioma	3.24E-13
Focal adhesion	1.19E-12
Proteasome	3.38E-12
Acute myeloid leukemia	3.15E-12
Neurotrophin signaling pathway	1.39E-11
Insulin signaling pathway	2.57E-11
Small cell lung cancer	2.98E-11
T cell receptor signaling pathway	3.35E-10
ErbB signaling pathway	4.29E-10
Non-small cell lung cancer	4.09E-10
Colorectal cancer	7.45E-09
Cell cycle	9.14E-09
Fc epsilon RI signaling pathway	9.32E-09
Type II diabetes mellitus	2.00E-08
Adherens junction	4.16E-08
Melanoma	3.49E-07
Fc gamma R-mediated phagocytosis	3.46E-07
Adipocytokine signaling pathway	7.42E-07
Renal cell carcinoma	1.42E-06
Bladder cancer	1.72E-06
Jak-STAT signaling pathway	2.82E-06
Chemokine signaling pathway	3.28E-06
Endometrial cancer	3.65E-06
Notch signaling pathway	6.27E-06
TGF-beta signaling pathway	6.48E-06
Natural killer cell mediated cytotoxicity	6.30E-06
Aldosterone-regulated sodium reabsorption	7.51E-06
Thyroid cancer	1.01E-05
VEGF signaling pathway	1.44E-05
Progesterone-mediated oocyte maturation	8.87E-05
mTOR signaling pathway	9.80E-05
Leukocyte transendothelial migration	1.25E-04
Oocyte meiosis	1.57E-04
Pathogenic Escherichia coli infection	2.39E-04
Ubiquitin mediated proteolysis	3.04E-04
p53 signaling pathway	3.29E-04
Wnt signaling pathway	3.97E-04
NOD-like receptor signaling pathway	5.10E-04
MAPK signaling pathway	8.07E-04
Regulation of actin cytoskeleton	0.001
Toll-like receptor signaling pathway	0.002
Apoptosis	0.003
Epithelial cell signaling in Helicobacter pylori infection	0.004
Gap junction	0.01
RIG-I-like receptor signaling pathway	0.02
Tight junction	0.02
GnRH signaling pathway	0.02
Long-term depression	0.04

^*Bejamini-Hochberg correction.